Quantbot Technologies LP Tg Therapeutics, Inc. Transaction History

Quantbot Technologies LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$6.68 - $18.81 $2,438 - $6,865	365 New	365 $6,000
Q1 2023 May 12, 2023	SELL	$10.23 - $19.34 $464,861 - $878,828	-45,441 Reduced 84.2%	8,530 $128,000
Q4 2022 Feb 13, 2023	BUY	$5.01 - $11.83 $43,441 - $102,577	8,671 Added 19.14%	53,971 $638,000
Q3 2022 Nov 07, 2022	SELL	$4.57 - $8.4 $227,083 - $417,396	-49,690 Reduced 52.31%	45,300 $268,000
Q2 2022 Aug 09, 2022	BUY	$3.74 - $10.66 $355,262 - $1.01 Million	94,990 New	94,990 $403,000
Q1 2021 May 14, 2021	SELL	$41.61 - $54.3 $70,986 - $92,635	-1,706 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$25.27 - $54.9 $17,815 - $38,704	705 Added 70.43%	1,706 $88,000
Q3 2020 Nov 16, 2020	BUY	$18.49 - $27.24 $8,634 - $12,721	467 Added 87.45%	1,001 $26,000
Q2 2020 Aug 13, 2020	BUY	$8.9 - $21.84 $2,865 - $7,032	322 Added 151.89%	534 $10,000
Q1 2020 May 13, 2020	SELL	$7.14 - $15.99 $17,043 - $38,168	-2,387 Reduced 91.84%	212 $2,000
Q4 2019 Feb 10, 2020	BUY	$5.1 - $11.2 $13,254 - $29,108	2,599 New	2,599 $28,000
Q2 2018 Aug 13, 2018	SELL	$12.5 - $15.0 $47,775 - $57,330	-3,822 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$8.7 - $16.8 $33,251 - $64,209	3,822 New	3,822 $54,000

338

88.3M

2.35M

1.7M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.29B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.